










































An intronic LINE-1 insertion in MERTK is strongly associated
with retinopathy in Swedish Vallhund dogs
Citation for published version:
Everson, R, Pettitt, L, Forman, OP, Dower-Tylee, O, McLaughlin, B, Ahonen, S, Kaukonen, M, Komáromy,
AM, Lohi, H, Mellersh, CS, Sansom, J & Ricketts, SL 2017, 'An intronic LINE-1 insertion in MERTK is
strongly associated with retinopathy in Swedish Vallhund dogs', PLoS ONE, vol. 12, no. 8, e0183021.
https://doi.org/10.1371/journal.pone.0183021
Digital Object Identifier (DOI):
10.1371/journal.pone.0183021
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 12. Sep. 2019
RESEARCH ARTICLE
An intronic LINE-1 insertion in MERTK is
strongly associated with retinopathy in
Swedish Vallhund dogs
Richard Everson1¤, Louise Pettitt2, Oliver P. Forman2, Olivia Dower-Tylee2,
Bryan McLaughlin2, Saija Ahonen3,4, Maria Kaukonen3,4, Andra´s M. Koma´romy5,6,
Hannes Lohi3,4, Cathryn S. Mellersh2, Jane Sansom1, Sally L. Ricketts2*
1 Centre for Small Animal Studies–Ophthalmology Unit, Animal Health Trust, Kentford, Newmarket, Suffolk,
United Kingdom, 2 Canine Genetics Research Group, Kennel Club Genetics Centre, Animal Health Trust,
Kentford, Newmarket, Suffolk, United Kingdom, 3 Department of Veterinary Biosciences and Research
Programs Unit, Molecular Neurology, University of Helsinki, Helsinki, Finland, 4 The Folkha¨lsan Institute of
Genetics, Helsinki, Finland, 5 Department of Small Animal Clinical Sciences, College of Veterinary Medicine,
Michigan State University, East Lansing, Michigan, United States of America, 6 Department of Clinical
Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United
States of America
¤ Current address: The Royal Veterinary College, North Mymms, Hatfield, Herts, United Kingdom
* sally.ricketts@aht.org.uk
Abstract
The domestic dog segregates a significant number of inherited progressive retinal diseases,
several of which mirror human retinal diseases and which are collectively termed progres-
sive retinal atrophy (PRA). In 2014, a novel form of PRA was reported in the Swedish Vall-
hund breed, and the disease was mapped to canine chromosome 17. The causal mutation
was not identified, but expression analyses of the retinas of affected Vallhunds demon-
strated a 6-fold increased expression of the MERTK gene compared to unaffected dogs.
Using 24 retinopathy cases and 97 controls with no clinical signs of retinopathy, we repli-
cated the chromosome 17 association in Swedish Vallhunds from the UK and aimed to elu-
cidate the causal variant underlying this association using whole genome sequencing
(WGS) of an affected dog. This revealed a 6–8 kb insertion in intron 1 of MERTK that was
not present in WGS of 49 dogs of other breeds. Sequencing and BLASTN analysis of the
inserted segment was consistent with the insertion comprising a full-length intact LINE-1 ret-
roelement. Testing of the LINE-1 insertion for association with retinopathy in the UK set of
24 cases and 97 controls revealed a strong statistical association (P-value 6.0 x 10−11) that
was subsequently replicated in the original Finnish study set (49 cases and 89 controls (P-
value 4.3 x 10−19). In a pooled analysis of both studies (73 cases and 186 controls), the
LINE-1 insertion was associated with a ~20-fold increased risk of retinopathy (odds ratio
23.41, 95% confidence intervals 10.99–49.86, P-value 1.3 x 10−27). Our study adds further
support for regulatory disruption of MERTK in Swedish Vallhund retinopathy; however, fur-
ther work is required to establish a functional overexpression model. Future work to charac-
terise the mechanism by which this intronic mutation disrupts gene regulation will further
improve the understanding of MERTK biology and its role in retinal function.
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Introduction
In the domestic dog, there are a large number of inherited and progressive retinal diseases,
which are collectively termed progressive retinal atrophy (PRA). These diseases affect the pho-
toreceptors, the retinal pigment epithelium (RPE) or both, and have been identified in many
breeds [1–19]. PRA is always bilateral and almost always leads to blindness [20]. Many of these
retinopathies are mirrored in human patients, and dogs have been used as animal models for
human diseases such as Leber congenital amaurosis [2], retinitis pigmentosa [4] and achroma-
topsia [16]. Identification of each specific genetic mutation responsible provides a greater
understanding of each disease and in dogs allows identification of affected individuals and car-
riers before breeding, which can lead to the reduction of incidence or eradication of the disease
from the population. In humans this knowledge also raises the possibility of treatment of
affected individuals using gene replacement therapy [21–22].
In 2014, Cooper et al. reported a novel form of PRA in the Swedish Vallhund [23]. This was
the first published, peer-reviewed report of the condition, although it had been recognised by
ophthalmologists in Sweden and Finland as early as the 1990s, later in the USA [24] and in the
UK in 2011 (by JS (co-author)). Cooper et al. described a characteristic red-brown discoloura-
tion of the tapetal fundus, followed later by thinning of the retina and associated visual deficits.
The age of onset was reported to be variable, presenting a challenge when it came to assessing
the likely mode of inheritance, although it appeared most likely to be autosomal recessive. A
later genome-wide association study (GWAS) investigating the genetic cause of this form of
PRA identified a region on canine chromosome 17 that showed a strong reproducible associa-
tion with the disease [25]. Several variants in coding regions of functional candidate genes
were subsequently identified by targeted resequencing of the associated region, but none of
these variants appeared to be the causal mutation. However, expression analyses of the retina
in affected Vallhunds demonstrated a 6-fold increased expression of the MERTK gene, suggest-
ing that this PRA in Swedish Vallhunds could be caused by a variant affecting the regulation of
that gene [25].
Identification of the genetic cause of PRA in the Swedish Vallhund is particularly important
because of the variation in age of onset of the condition, which makes it very challenging to
reduce its incidence by selective breeding based on eye examinations alone. The aim of this
study was to further investigate the genetic cause of PRA in the Swedish Vallhund, using eye
examination findings in the UK and Finnish populations of Swedish Vallhunds, with the ulti-
mate aim of providing a DNA test that can be used to identify individuals carrying a disease-
associated mutation prior to breeding.
Materials and methods
Study samples
Samples from dogs in the study included a set of 121 Swedish Vallhunds predominantly from
the UK (one dog lived in Holland, two in Canada), and a set of 145 from Finland. All samples
were taken from privately owned pet dogs. Buccal mouth swabbing was conducted either by
the examining veterinarian or by the owner, following informed oral and/or written owner
consent. UK dogs were recruited through publicity provided by the UK Swedish Vallhund
Society and interested breeders, and were examined at events held across England. The Finnish
dogs were recruited for the study via word of mouth, breed club publicity, or via study-specific
webpages/social media. All dogs were examined by specialist veterinary ophthalmologists (JS,
AK, and Pa¨ivi Vanhapelto), or a specialist in training (RE). The examination included slit-
lamp biomicroscopy (SL-15; Kowa Company Ltd, Tokyo, Japan) to examine the anterior
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segment and the use of topical tropicamide (Mydriacyl 1% eye drops; Alcon Laboratories UK
Ltd, Camberley, UK) to achieve mydriasis and facilitate a detailed fundic examination. Fundu-
scopy was performed using a binocular indirect ophthalmoscope (Omega 500; Heine Optotech-
nik, Herrsching, Germany) and a condensing lens (20D double aspheric lens; Volk Optical Inc.,
Mentor, Ohio, USA). Using the phenotype described by Cooper et al. (2014) [23], dogs were
considered affected by the retinopathy if patches of red-brown pigment were seen starting at the
periphery of the tapetal fundus as an early finding and appearing distinct from the darker pig-
ment in the non-tapetal fundus. The presence of hyperreflective areas in the tapetal fundus was
often but not always a later finding and attenuation of the retinal vasculature was only seen in
very advanced cases of degeneration. The non-tapetal fundus appeared to be unaffected. The
normal heterogeneity in the RPE can make the early diagnosis of this disease difficult as it
appears to start at the periphery of the tapetum. In normal eyes there is considerable variation
at this transitional zone with a normal variation in the degree of pigmentation in the RPE and
reflectivity. To compound this, intense illumination from the ophthalmoscope can obscure the
early pigmentary disturbance that occurs at this location. No specific age cut-off was used to
determine that a dog was unaffected by the retinopathy, as a large variability in age at diagnosis
has been reported (as early as 1.1 years and as late as 12.6 years) [23]. For the purposes of the
study, a dog was considered to be unaffected if it had no signs of the retinopathy at examination,
accepting that a proportion of these dogs may go on to develop the disease later. Buccal swabs
were taken for DNA extraction from all dogs in the UK study set, which was carried out using a
QIAamp DNA Blood Midi Kit (Qiagen, Manchester, UK). EDTA-blood samples were collected
from dogs in the Finnish study set (25). The study was conducted with approval from the Ani-
mal Health Trust Ethics Committee (Project No. 33_2013) and the County Administrative
Board of Southern Finland ESLH-2009-07827/Ym-23.
Genotyping and statistical analysis
SNP BICF2G630207991 was genotyped using an allelic discrimination assay using an ABI Ste-
pOne real-time thermal cycler. Primer sequences were: CCAATCAGAAGGGAAACAGGT (for-
ward); GCCAGGTTGAGGAATACTTGG (reverse); 5’-HEX-CTAGCTTGTGACCAGGAATTCAG
GA-BHQ-3’ (C allele); 5’-FAM-AGCTTGTGATCAGGAATTCAGGAAA-BHQ-3’ (T allele).
Primers used to amplify across the MERTK intron 1 LINE-1 insertion were CGTTTACCTAAT
TACAGTCCCAGA (forward primer) and CAACTTAATGTGTGCTGCTTAGGA (reverse primer).
For the PCR reaction we used PrimerSTAR GXL DNA Polymerase (Takara Clontech, Saint-
Germain-en-Laye, France) that is optimised for difficult and large amplicons. PCR comprised
30 cycles of 98˚C for 10 seconds, 60˚C for 15 seconds, and 68˚C for 8 minutes. The MERTK
intron 1 LINE-1 insertion was genotyped by fragment analysis on an ABI 3130XL Genetic
Analyzer using HOT STAR Taq (Qiagen, Manchester, UK); a common forward primer (GAA
TAAACACATCCCTGGCATT); a wild-type reverse primer (TGCAACTTAATGTGTGCTGCT); a
mutant reverse primer (CTACTCTTCCGCCATCTTGCT); and the addition of 0.05 μM (final
concentration) fluorescently labelled forward primer. PCR cycling consisted of an initial 95˚C
denaturation step for 5 minutes, followed by 35 cycles of 95˚C for 30 seconds, 60˚C for 30 sec-
onds, and 72˚C for 1 minute. Final elongation was 72˚C for 5 minutes. The association with
retinopathy was tested using the Fisher’s exact test. Linkage disequilibrium LD among variants
was assessed using pairwise correlation (r2). We used logistic regression and log-likelihood
ratio tests to compare a general model with a linear per allele model to assess the shape of the
association between the LINE-1 insertion and retinopathy and to compute the odds ratio for
the pooled UK and Finnish study sets. All of the above statistical analyses were conducted
using STATA 10.0 (College Station, TX, USA).
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Whole genome sequencing (WGS) and analysis
WGS was conducted for one UK case and one Finnish case and its affected sire. Since the UK
DNA sample was derived from a buccal swab, it was checked for integrity (percentage of dog
DNA) by obtaining a random distribution of WGS reads (~10,000) using a MiSeq platform
(Illumina). The UK case selected for WGS showed an aligned read percentage of 89.4%. (As
samples from the Finnish dogs were derived from whole blood, this stage could be omitted.)
PCR-free library preparation and paired-end sequencing (100 bp reads) was carried out for
the UK case at the High-Throughput Genomics Group, Wellcome Trust Centre for Human
Genetics, University of Oxford, UK on one lane of an Illumina HiSeq4000. The Finnish dogs
were sequenced at the University of Bern, Switzerland using a PCR-free library preparation
and pooled in a set of eight dogs sequenced over six lanes of a HiSeq2500. Sequence reads were
aligned to the canine reference genome (CanFam 3.1) using BWA-MEM [26] and SNP/inser-
tion-deletion (in-del) calls were made by GATK HaplotypeCaller (v.3.4) [27] using GATK best
practices. WGS data can be found in the European Nucleotide Archive, study accession num-
bers PRJEB21485 and PRJNA394814.
Characterisation of LINE-1 insertion
A library was constructed from multiple PCR amplicons of a single case for the LINE-1 inser-
tion using the above flanking primers and a modified version of the Illumina Nextera XT kit.
After the initial tagmentation stage, a 1X AMPure XP bead purification was performed (Beck-
man Coulter, High Wycombe, UK), and in the following PCR stage KAPA HiFi HotStart
ReadyMix (Kapa Biosystems, Boston, MA, USA) was used instead of the Nextera PCR Master
Mix (NPM). Cycling conditions were 72˚C for 3 minutes, 98˚C for 30 seconds, then 12 cycles
of 98˚C for 10 seconds, 63˚C for 30 seconds, and 72˚C for 3 minutes, with a final 72˚C for 1
minute followed by a hold at 10˚C. After the final bead purification the product was resus-
pended in 25 μl ultrapure water. The library was quantified by qPCR using the KAPA library
quantification kit (Kapa Biosystems, Boston, MA, USA). Sequencing of the library was per-
formed on one run of an Illumina MiSeq instrument, generating paired-end reads of 151 bp in
length. De novo sequence assembly was carried out using SOAPdenovo2 [28] to create contigs
from a subset of the MiSeq data.
Results
We first sought to replicate the previously published association for retinopathy in the Swedish
Vallhund on canine chromosome 17 by genotyping the top SNP from the previously published
GWAS (BICF2G630207991 at CanFam 3.1 co-ordinate 36,400,229) [25] in a UK-based set of
24 retinopathy cases and 97 controls. This SNP showed a strong statistical association with ret-
inopathy in the UK dogs—P-value for Fisher’s exact test: 4.7 x 10−9—and was directionally
consistent with Ahonen et al. [25]. Genotype distributions for SNP BICF2G630207991 in the
case and control groups of the UK study set are shown in Table 1A.
Next we utilised PCR-free WGS to generate complete sequence spanning the genomic inter-
val defined by the previous GWAS data [25] (CanFam 3.1 chr17:34,421,056–40,576,539) using a
UK case that possessed two copies of the risk allele (C) at SNP BICF2G630207991. Median read
depth of the UK case was 21X with 97% of bases achieving at least 10X read depth; 92.2% of
reads mapped to the reference genome. Median read depth of the Finnish dogs were 24X for the
case and 21X for the affected sire with 97% of bases achieving at least 10X read depth; 99% of the
reads mapped to the reference genome. Given previous evidence for involvement of the MERTK
gene, we initially focused on the region directly encompassing MERTK (chr17:36,336,729–
36,445,380) by visually scanning sequence reads in IGV (Integrative Genomics Viewer) [29]. We
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initially compared the Swedish Vallhund case with WGS from three dogs each of a different breed
that have been generated for the study of other diseases in our laboratory and were not expected
to share the retinopathy mutation. This analysis revealed a 15 bp region of increased read depth
followed by a sharp truncation of reads in intron 1 of the MERTK gene (chr17:36,338,043–
36,338,057; 62,172 bp upstream of SNP BICF2G630207991) and 1,006 bp downstream of the end
of the first predicted exon, suggestive of an insertion, or duplication (Fig 1). This feature was pres-
ent in the retinopathy case but was not present in 49 additional WGS of different breeds. The
same insertion was also found in the WGS from the Finnish Swedish Vallhunds. Both the Finnish
case and its affected sire were homozygous.
BLASTN analysis [30] of the duplicated segment and part of the sequencing reads that were
soft-clipped by BWA (Fig 1) revealed multiple hits across the canine genome with a LINE-1
element as the top signal, indicating that the insertion involves a retrotransposon. To further
characterise the insertion, we amplified across it using flanking primers. Agarose gel analysis
of a subset of two cases and two controls revealed an approximate 6–8 kb fragment for cases,
and the 180 bp CanFam 3.1 reference-predicted fragment size for controls (Fig 2). We
attempted to sequence the 6–8 kb case amplicon using a MiSeq instrument (Illumina) and
used de novo assembly to construct a 6.401 kb contig of the insertion between the two dupli-
cated segments, ending with a low complexity run of A nucleotides that we were unable to
fully decipher. BLAST analysis of this contig aligns with 99% identity to the canine L1-Y_CF
consensus sequence found in RepBase [31–32]. Analysis of the insertion sequence using NCBI
ORF Finder revealed a full-length LINE-1 element comprising the 15 bp target site duplication
(Fig 1), a 5’UTR, 900 bp 5’ ORF1, a 49 bp intergenic spacer, a 3,828 bp 3’ ORF2, a 3’UTR and
poly(A) tail. The LINE-1 element has been inserted in the same orientation as the MERTK
gene.
Table 1. Genotypes for top GWAS SNP and LINE-1 insertion in Swedish Vallhunds from the UK and Finland.
Table 1a UK dogs (24 cases and 97 controls)
Retinopathy status
SNP_BICF2G630207991 genotypea Case n (freq.) Control n (freq.) Total
T/T 3 (0.13) 25 (0.26) 28
T/C 6 (0.25) 67 (0.69) 73
C/C 15 (0.63) 5 (0.05) 20 P-value: 4.7 x 10−9
LINE-1 insertion genotype
Wildtype 3 (0.13) 28 (0.29) 31
Heterozygote 6 (0.25) 67 (0.69) 73
LINE-1 ins 15 (0.63) 2 (0.02) 17 P-value 6.0 x 10−11
Table 1b Finnish dogs (49 cases and 89 controls)
Retinopathy status
SNP_BICF2G630207991 genotypea Case n (freq.) Control n (freq.) Total
T/T 0 (0.00) 26 (0.29) 26
T/C 7 (0.14) 51 (0.57) 58
C/C 42 (0.86) 12 (0.13) 54 P-value 1.3 x 10−17
LINE-1 insertion genotype
Wildtype 0 (0.00) 28 (0.31) 28
Heterozygote 7 (0.14) 51 (0.57) 58
LINE-1 ins 42 (0.86) 10 (0.11) 52 P-value 4.3 x 10−19
a For SNP_BICF2G630207991 the risk allele is C
https://doi.org/10.1371/journal.pone.0183021.t001
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We developed a genotyping assay for the LINE-1 insertion and tested it for association with
retinopathy in the UK set of 24 cases and 97 controls and found a strong statistical association
(P-value 6.0 x 10−11) (Table 1A). The LINE-1 insertion was correlated to the top GWAS SNP
at an r2 of 0.94 in the UK study set. Log likelihood ratio tests based on logistic regression sug-
gested that the association was non-linear, indicating an autosomal recessive mode of inheri-
tance that supports previous suggestions [23]. We consequently sought to replicate the LINE-1
insertion association in the Finnish samples that had been part of the original GWAS study
[25]. In a set of 49 cases and 89 controls, the LINE-1 insertion showed a strong association
with retinopathy (P-value 4.3 x 10−19) and this association was two orders of magnitude stron-
ger than the top GWAS SNP in this study set (P-value 1.3 x 10−17) (Table 1B). The correlation
between the LINE-1 insertion and top GWAS SNP was r2 of 0.97 in the Finnish study set and,
as for the UK study set, the association appeared non-linear. In a pooled analysis of both study
sets (comprising a total of 73 cases and 186 controls) using logistic regression with adjustment
Fig 1. IGV Illustration of the LINE-1 insertion in intron 1 of the MERTK gene. A. The upper panel shows the Swedish Vallhund case, and the
middle and lower panels represent two control WGS for comparison (a Labrador-Golden retriever cross and a Siberian Husky, respectively). The 15
bp duplicated sequence that is the LINE-1 insertion point is boxed. The CanFam 3.1 reference sequence (Boxer) is shown above and below the figure.
B. Diagram to clarify the LINE-1 insertion in the Swedish Vallhund case. The 15 bp duplication is shown in orange, and soft-clipped bases in sequence
reads at the start and end of the LINE-1 insertion (from the upper panel of A) are shown in dark and light blue, respectively. The line joining these two
sequences represents the 6.401 kb of LINE-1 insertion sequence.
https://doi.org/10.1371/journal.pone.0183021.g001
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for study, the LINE-1 insertion was associated with a ~20-fold increased risk of retinopathy
(odds ratio 23.41, 95% confidence intervals 10.99–49.86, P-value 1.3 x 10−27).
We also screened the remainder of the genomic region spanning the MERTK gene
(chr17:36,336,729–36,445,380) and found two additional intronic variants that were present in
only the retinopathy case compared to the 49 other WGS. One has been previously tested by
Ahonen et al. [25] (CanFam 3.1 co-ordinate chr17:36,410,244) and was found to be weakly
associated with retinopathy, and subsequent genotyping of the other (CanFam 3.1 co-ordinate
Fig 2. Agarose gel electrophoresis analysis of PCR amplification of the LINE-1 insertion in UK Swedish
Vallhund retinopathy cases and controls. Lanes 1 and 7 are a 2-Log DNA ladder (New England Biolabs, Hitchin,
UK); Lanes 2 and 3 are controls negative for the LINE-1 insertion; Lanes 4 and 5 are cases positive for the insertion;
Lane 6 is a non-template control.
https://doi.org/10.1371/journal.pone.0183021.g002
An intronic LINE-1 insertion in MERTK is strongly associated with retinopathy in Swedish Vallhund dogs
PLOS ONE | https://doi.org/10.1371/journal.pone.0183021 August 16, 2017 7 / 14
chr17:36,399,739) in the UK study set of 24 cases and 97 controls revealed a strong statistical
association equal to SNP BICF2G630207991 (P-value 4.7 x 10−9) to which it showed perfect
correlation. However, as the association was weaker than for the LINE-1 insertion this variant
was not considered further. Testing of the LINE-1 insertion in a multi-breed panel of 92 dogs
comprised of 31 breeds found no evidence of the insertion in these breeds. We also compared
the Vallhund WGS to the 49 WGS of other breeds for the whole associated interval above. This
identified 2,108 variants, of which 108 were homozygous for one allele in the Vallhund and
homozygous for an alternative allele in the dog reference genome and all other 49 WGS. Two
of these were coding indel variants in the following genes: FOXI3 (chr17:38,032,793) and
PROM2 (chr17:34,827,666), but neither are plausible candidates for retinopathy. The FOXI3
variant comprised a 9 bp insertion located within a tandem repeat sequence not well conserved
following CLUSTAL [33] alignment of the canine protein sequence with that of 27 placental
mammals (data not shown). The PROM2 variant was a 25 bp insertion also situated within a
tandemly repeating sequence that was polymorphic amongst the 49 WGS and was not well
conserved following CLUSTAL alignment of the canine protein sequence with 31 placental
mammals (data not shown).
Discussion
Our study has independently replicated a previously published association with retinopathy
and the MERTK locus in the Swedish Vallhund and has identified a LINE-1 repeat element
insertion in intron 1 of the MERTK gene that shows a strong statistical association with reti-
nopathy. Whilst the LINE-1 insertion is a very strong candidate causal mutation, the mecha-
nism underlying the association requires further elucidation, as we did not have access to
tissue samples from affected UK dogs with which to conduct RNA or protein analyses. How-
ever, our findings are consistent with observations from the previous genetic study, where
interestingly, whilst there was no structural difference in MERTK mRNA transcripts amongst
two Swedish Vallhund retinopathy cases from Finland (neuro-retina and RPE) and an unaf-
fected dog of a different breed, an analysis of MERTK expression levels demonstrated a
6.5-fold increased level of MERTK expression in four Vallhund cases when compared to two
controls of other breeds [25].
LINE-1 retrotransposons are common in mammalian genomes [34], including humans
and dogs [35,36] and their integration into intronic genomic DNA has been associated with
several diverse diseases in both species, although mostly with a concurrent alteration in struc-
ture of the mRNA of the gene affected and/or with a significant decrease in gene expression
[35, 37–43]. The full-length LINE-1 insertion shown in this study is similar to one associated
with reduced expression of the aryl hydrocarbon receptor gene involved in liver metabolism in
Irish Wolfhounds, although this LINE-1 sequence contains frame shifts in both ORFs [42],
whereas the LINE-1 insertion identified in the Vallhund appears intact. There are several
potential mechanisms by which the insertion of a LINE-1 element can affect expression of
nearby genes; by introducing regulatory elements or promoters that could act as enhancers, or
by the creation of 5’ and 3’ truncated mRNAs as well as the intact mRNA that could affect/
mask the assessment of normal gene expression [37, 38, 44]. It could also be possible that the
LINE-1 insertion disrupts a cis-acting regulatory element within intron 1 of the gene. To help
elucidate this, functional experiments using genome editing techniques such as CRISPR could
potentially examine MERTK expression levels in cell lines established from retinal tissue of
affected dogs with subsequent partial and full removal of the LINE-1 insertion. Further charac-
terisation of MERTK mRNA isoforms in affected Swedish Vallhunds will also be important to
confirm that the increased expression of MERTK shown in the previous study [25] is that of
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intact MERTK and not alternative truncated transcripts that could affect the normal function
of the MERTK protein. Protein expression studies would also be useful to establish whether
MERTK levels are different between affected and unaffected Swedish Vallhunds.
The role of MERTK in driving the epithelial cell phagocytosis of apoptotic cells (efferocyto-
sis) of photoreceptor outer segments by the RPE as part of the regular shedding and replace-
ment of these cells in the retina is well established [45] and was first confirmed in the Royal
College of Surgeons (RCS) naturally occurring rat model of retinal dystrophy. A mutation in
the MERTK gene was identified as causing a deficiency in this process, leading to the build-up
of cellular debris and the deterioration of the photoreceptors [46]. Following this, and the
identification of mutations in humans with retinitis pigmentosa where loss of MERTK func-
tion has also been demonstrated [47, 48], its biology has been widely investigated due to the
potential of gene therapy to correct deficiencies in MERTK expression caused by mutations in
the gene [49]. However, the scenario that is suggested by the combined results of this and the
previous study is converse to the findings in human and rat and involves a similar disease phe-
notype caused by suggested upregulation of the MERTK gene. The possible mechanisms for
how this could occur have been discussed in the previous study [25]. MERTK is a transmem-
brane protein of the MER/AXL/TYRO3 receptor tyrosine kinase family, and is also a proto-
oncogene that appears upregulated in cancers such as mammary tumours, cell lines from
which have been shown to demonstrate an enhanced level of efferocytosis [50]. In the retina,
MERTK has two forms; a membrane-bound form that initiates efferocytosis and a soluble
form (sMERTK) that inhibits this process in a negative feedback loop, ensuring that phagocy-
tosis in the RPE occurs only over a limited time duration [51, 52]. Therefore efferocytosis of
photoreceptor outer segments is closely controlled in RPE cells, but how any overexpression of
MERTK would have an effect on this delicate balance between the MERTK and sMERTK mol-
ecules needs to be clarified. Indeed the establishment that it is intact MERTK that is being over-
expressed in affected Vallhunds is important, as is whether this occurs before the development
of disease and that it is therefore a cause and not a consequence of retinopathy. Despite these
uncertainties, the identification of the genetic defect underlying this naturally occurring canine
overexpression model for MERTK is a novel and exciting finding and could therefore inform
future studies of MERTK in both human and canine retinal disease.
In both study sets combined, 6% of controls and 22% of cases were discordant in terms of
their genotype-phenotype status and therefore warrant further discussion. In the UK study set
these are two controls that genotyped homozygous for the LINE-1 insertion and were free of
ocular disease at entry into the study in autumn 2014 (Table 1A). At this time one of the dogs
was 3 years 8 months old and the other 7 years 11 months old. The younger dog was re-exam-
ined in November 2015 by JS (co-author) at 4 years 11 months old and was still found to be
free of ocular disease. In the Finnish study set there were 10 controls that were homozygous
for the LINE-1 insertion and were free of ocular disease at examination (Table 1B). The age of
last eye examination for these 10 dogs ranged from 4.4–12.7 years (median 5.75) and so it is
again possible that clinical signs are yet to appear. This is consistent with the variability in age
of onset reported by Cooper et al. [23], who reported changes as early as 1.1 years and as late as
12.6 years of age. Cooper et al. suggest that possible explanations for this large variation in age
of onset include both genetic and environmental modifiers, and that these may also be respon-
sible for the variations in phenotype. Another possible explanation for the variation in pheno-
type could lie in the mosaicism of the RPE, which has marked variation between cells in the
content of melanin and lipofuscin. This is thought to arise by normal mechanisms regulating
gene expression, and could certainly account for some of the differences in phenotype [53].
The heterogeneous phenotype in the affected Vallhunds could be due to the unusual overex-
pression of MERTK. Interestingly, a recent study has identified the Tyro3 gene as a genetic
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modifier of retinopathy in the Mertk knockout mouse, with allelic variation at Tyro3 moderat-
ing the clinical manifestation of the disease [54]. There are also suggestions that the activity of
transposable elements varies within tissues, so any mechanism by which a gene-specific LINE-
1 insertion exerts effects on nearby gene expression may be variable at a cellular level and mod-
ulated by epigenetic means [55].
By contrast, three of the UK cases do not carry the LINE-1 insertion and six are only carriers
(Table 1A); amongst the Finnish cases there are seven carriers of the LINE-1 insertion. We did
not find any statistical evidence in our study sets that carriers have an increased risk of disease
and our analyses strongly signified an autosomal recessive mode of inheritance. Overall our data
showed 83% concordance for cases and 94% for controls, with 57 out of the 69 dogs that possessed
two copies of the LINE-1 insertion being affected by retinopathy (Table 1). This level of concor-
dance is broadly similar to that found for other forms of PRA where the discordancy in cases is
suggested to be due to genetic heterogeneity of the condition [9–11, 56]. Genetic heterogeneity is
a scenario typical to PRA in many breeds [1] and indeed in human retinitis pigmentosa [57] and
so may also be the situation for retinopathy in the Vallhund. This condition does represent a form
of PRA involving both the RPE and the photoreceptors, although its clinical presentation and the
involvement of MERTK suggests that this retinopathy is primarily related to a defect in the RPE.
Future studies involving the discordant cases in this study may uncover additional regions of the
canine genome that are involved in the disease in the Swedish Vallhund.
Conclusions
We have identified a LINE-1 insertion in intron 1 of the MERTK gene that is strongly associ-
ated with retinopathy in the Swedish Vallhund, and which is a strong candidate for a causative
mutation. This study adds further support for regulatory disruption of the MERTK gene in
Swedish Vallhund retinopathy, although to establish this functional overexpression model
more work is required to further investigate MERTK biology in retinal function. Further char-
acterisation of how this LINE-1 insertion modulates MERTK expression may improve the
understanding of its regulation and whether there are motifs disrupted by its insertion. Our
results will enable the development of a DNA-based breeding tool that directly assays this
mutation in the Swedish Vallhund. This will help breeders to avoid producing clinically
affected dogs and will also aid veterinary ophthalmologists with differential diagnosis of the
condition in the breed.
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